Sanofi (SNY) - Q3 FY12/26 Earnings Review
Sanofi Q3 sales rose 14.3% at constant currency to €14.4 billion, led by 34.8% Dupixent growth, prompting a second increase to FY26…
NASDAQ
Cap as of Nov 16 3 stories
Get SNY news in Claude, ChatGPT or your own code. See plans
Sanofi Q3 sales rose 14.3% at constant currency to €14.4 billion, led by 34.8% Dupixent growth, prompting a second increase to FY26…
Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.
Regeneron and Sanofi expanded their antibody partnership, giving REGN $1 billion upfront, up to $7 billion in milestones and a 50:50 global…
Letters that discuss SNY.
Companies the stories above are also about, besides SNY.